Behcet's syndrome pathophysiology and potential therapeutic targets

被引:51
|
作者
Emmi, Giacomo [1 ]
Silvestri, Elena [1 ,2 ,3 ]
Squatrito, Danilo [2 ,3 ]
D'Elios, Mario Milco [1 ,2 ,3 ]
Ciucciarelli, Lucia [1 ]
Prisco, Domenico [1 ,2 ,3 ]
Emmi, Lorenzo [2 ,3 ]
机构
[1] Univ Florence, Dept Expt & Clin Med, I-50134 Florence, Italy
[2] AOU Careggi, SOD Patol Med, Ctr Autoimmune Syst Dis, Behcet Ctr, Florence, Italy
[3] AOU Careggi, Lupus Clin, Florence, Italy
关键词
Behcet syndrome pathophysiology; Behcet treatment; Biologic therapy; Anti-TNF-alpha; IL-1 blocking agents; GENOME-WIDE ASSOCIATION; TUMOR-NECROSIS-FACTOR; V-GAMMA-9/V-DELTA-2; T-LYMPHOCYTES; FAMILIAL MEDITERRANEAN FEVER; INTERFERON ALPHA-2A; STREPTOCOCCUS-SANGUIS; DOUBLE-BLIND; TNF FAMILY; DISEASE; UVEITIS;
D O I
10.1007/s11739-013-1036-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet syndrome is a systemic inflammatory disorder characterized by multiorgan involvement such as oral and genital ulcers, uveitis, skin lesions as well as by less frequent, but often more severe, central nervous system and vascular manifestations. The pathogenetic mechanisms are still incompletely known; however the interaction between a specific genetic background and environmental or infectious factors certainly contributes to the immune dysregulation that characterizes this disease. The discovery of new immunological pathways in Behcet syndrome pathogenesis may help us to set up new treatments. In this review, we will focus our attention on the possible mechanisms underlying Behcet syndrome pathogenesis and their potential role as novel therapeutic targets.
引用
收藏
页码:257 / 265
页数:9
相关论文
共 50 条
  • [1] Behçet’s syndrome pathophysiology and potential therapeutic targets
    Giacomo Emmi
    Elena Silvestri
    Danilo Squatrito
    Mario Milco D’Elios
    Lucia Ciucciarelli
    Domenico Prisco
    Lorenzo Emmi
    Internal and Emergency Medicine, 2014, 9 : 257 - 265
  • [2] New therapeutic solutions for Behcet's syndrome
    Vitale, Antonio
    Rigante, Donato
    Lopalco, Giuseppe
    Emmi, Giacomo
    Bianco, Maria Teresa
    Galeazzi, Mauro
    Iannone, Florenzo
    Cantarini, Luca
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (07) : 827 - 840
  • [3] Cytokines in Sjogren's syndrome: potential therapeutic targets
    Roescher, Nienke
    Tak, Paul P.
    Illei, Gabor G.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) : 945 - 948
  • [4] Behcet's Syndrome
    Xenitidis, Theodoros
    Henes, Joerg Christoph
    AKTUELLE RHEUMATOLOGIE, 2019, 44 (04) : 262 - 275
  • [5] Cardiorenal syndrome: pathophysiology and potential targets for clinical management
    Hatamizadeh, Parta
    Fonarow, Gregg C.
    Budoff, Matthew J.
    Darabian, Sirous
    Kovesdy, Csaba P.
    Kalantar-Zadeh, Kamyar
    NATURE REVIEWS NEPHROLOGY, 2013, 9 (02) : 99 - 111
  • [6] Pathophysiology of Behcet's disease
    Houman, M. H.
    Feki, N. Bel
    REVUE DE MEDECINE INTERNE, 2014, 35 (02): : 90 - 96
  • [7] Behcet's syndrome
    Pleyer, U.
    Stuebiger, N.
    Koetter, I.
    GEFASSCHIRURGIE, 2019, 24 (02): : 144 - 151
  • [8] Behcet’s Syndrome
    Sam R. Dalvi
    Resit Yildirim
    Yusuf Yazici
    Drugs, 2012, 72 : 2223 - 2241
  • [9] THERAPEUTIC TARGETS FOR CUSHING'S SYNDROME
    Brown, A. E.
    Sorbera, L. A.
    Dulsat, C.
    Rosa, E.
    DRUGS OF THE FUTURE, 2012, 37 (12) : 855 - 862
  • [10] Purinergic receptors as potential therapeutic targets in Alzheimer's disease
    Woods, Lucas T.
    Ajit, Deepa
    Camden, Jean M.
    Erb, Laurie
    Weisman, Gary A.
    NEUROPHARMACOLOGY, 2016, 104 : 169 - 179